Skip to main content

Advertisement

Log in

New insights into vitamin D anticancer properties: focus on miRNA modulation

  • Review
  • Published:
Molecular Genetics and Genomics Aims and scope Submit manuscript

Abstract

Vitamin D anticancer properties are well known and have been demonstrated in many in vitro and in vivo studies. Mechanistic insights have given an explanation on how vitamin D exerts antineoplastic functions, which are mainly conducted via the canonical vitamin D receptor (VDR)–vitamin D response elements (VDRE) pathway. Numerous findings indicate that dietary components, including vitamin D, could exert chemopreventive effects through alterations of microRNA (miRNA) expression. As miRNAs have important roles in regulating diverse and vital cellular processes, it has been speculated that vitamin D’s non-classical effects, including anticancer effects, could be mediated through alterations of miRNA expression level. The current review focuses on up-to-date experimental data on modulation of miRNA expression by vitamin D treatment in cancer, obtained in a cell culture system, animal models and human cohorts. Reported findings in the review show that vitamin D modulates expression of numerous and diverse miRNAs specific for cancer types. Even in its early phases, with many questions remaining to be answered, dissecting the molecular pathways of vitamin D miRNA modulation is an emerging area of science. The complete unraveling of vitamin D molecular mechanisms will emphasize the vitamin D dietary component as a potential chemopreventive agent in cancer and personalized nutrition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T (1981) Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78:4990–4994

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Adlakha YK, Khanna S, Singh R, Singh VP, Agrawal A, Saini N (2013) Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRalpha expression and cholesterol homeostasis. Cell Death Dis 4:e780

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alimirah F, Peng X, Gupta A, Yuan L, Welsh J, Cleary M, Mehta RG (2016) Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells. Exp Cell Res 349:15–22

    Article  CAS  PubMed  Google Scholar 

  • Alvarez-Diaz S, Valle N, Ferrer-Mayorga G, Lombardia L, Herrera M, Dominguez O, Segura MF, Bonilla F, Hernando E, Munoz A (2012) MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Hum Mol Genet 21:2157–2165

    Article  CAS  PubMed  Google Scholar 

  • Bao BY, Yao J, Lee YF (2006a) 1alpha, 25-Dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis 27:1883–1893

    Article  CAS  PubMed  Google Scholar 

  • Bao BY, Yeh SD, Lee YF (2006b) 1alpha,25-Dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases. Carcinogenesis 27:32–42

    Article  CAS  PubMed  Google Scholar 

  • Beckett EL, Martin C, Duesing K, Jones P, Furst J, Yates Z, Veysey M, Lucock M (2015) Vitamin D receptor genotype modulates the correlation between vitamin D and circulating levels of let-7a/b and vitamin D intake in an elderly cohort. J Nutrigenet Nutrigenomics 7:264–273

    Article  Google Scholar 

  • Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ (2007) 1alpha,25-Dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther 6:1433–1439

    Article  CAS  PubMed  Google Scholar 

  • Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319–329

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Borkowski R, Du L, Zhao Z, McMillan E, Kosti A, Yang CR, Suraokar M, Wistuba II, Gazdar AF, Minna JD, White MA, Pertsemlidis A (2015) Genetic mutation of p53 and suppression of the miR-17 approximately 92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling. Cancer Res 75:666–675

    Article  CAS  PubMed  Google Scholar 

  • Chang S, Gao L, Yang Y, Tong D, Guo B, Liu L, Li Z, Song T, Huang C (2015) miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells. Oncotarget 6:7675–7685

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen Y, Du J, Zhang Z, Liu T, Shi Y, Ge X, Li YC (2014) MicroRNA-346 mediates tumor necrosis factor alpha-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases. Inflamm Bowel Dis 20:1910–1918

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen S, Zhu J, Zuo S, Ma J, Zhang J, Chen G, Wang X, Pan Y, Liu Y, Wang P (2015) 1,25(OH)2D3 attenuates TGF-beta1/beta2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells. Biochem Biophys Res Commun 468:130–135

    Article  CAS  PubMed  Google Scholar 

  • Chimento A, Sirianni R, Saturnino C, Caruso A, Sinicropi MS, Pezzi V (2016) Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment. Mini Rev Med Chem 16:699–709

    Article  CAS  PubMed  Google Scholar 

  • Colston K, Colston MJ, Feldman D (1981) 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108:1083–1086

    Article  CAS  PubMed  Google Scholar 

  • Craig TA, Zhang Y, Magis AT, Funk CC, Price ND, Ekker SC, Kumar R (2014) Detection of 1alpha,25-dihydroxyvitamin D-regulated miRNAs in zebrafish by whole transcriptome sequencing. Zebrafish 11:207–218

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704–714

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • de la Parra C, Castillo-Pichardo L, Cruz-Collazo A, Cubano L, Redis R, Calin GA, Dharmawardhane S (2016) Soy isoflavone genistein-mediated downregulation of miR-155 contributes to the anticancer effects of genistein. Nutr Cancer 68:154–164

    Article  PubMed  PubMed Central  Google Scholar 

  • Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684–700

    Article  CAS  PubMed  Google Scholar 

  • DiMarco-Crook C, Xiao H (2015) Diet-based strategies for cancer chemoprevention: the role of combination regimens using dietary bioactive components. Annu Rev Food Sci Technol 6:505–526

    Article  CAS  PubMed  Google Scholar 

  • Duggal J, Harrison JS, Studzinski GP, Wang X (2012) Involvement of microRNA181a in differentiation and cell cycle arrest induced by a plant-derived antioxidant carnosic acid and vitamin D analog doxercalciferol in human leukemia cells. Microrna 1:26–33

    Article  CAS  PubMed  Google Scholar 

  • Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289:F8-28

  • Dusso A, Gonzalez EA, Martin KJ (2011) Vitamin D in chronic kidney disease. Best Pract Res Clin Endocrinol Metab 25:647–655

    Article  CAS  PubMed  Google Scholar 

  • Enquobahrie DA, Williams MA, Qiu C, Siscovick DS, Sorensen TK (2011) Global maternal early pregnancy peripheral blood mRNA and miRNA expression profiles according to plasma 25-hydroxyvitamin D concentrations. J Matern Fetal Neonatal Med 24:1002–1012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Essa S, Denzer N, Mahlknecht U, Klein R, Collnot EM, Tilgen W, Reichrath J (2010) VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells. J Steroid Biochem Mol Biol 121:110–113

    Article  CAS  PubMed  Google Scholar 

  • Essa S, Reichrath S, Mahlknecht U, Montenarh M, Vogt T, Reichrath J (2012) Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines. Anticancer Res 32:383–389

    CAS  PubMed  Google Scholar 

  • Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ (2014) The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 14:342–357

    Article  CAS  PubMed  Google Scholar 

  • Fernandez-Garcia NI, Palmer HG, Garcia M, Gonzalez-Martin A, del Rio M, Barettino D, Volpert O, Munoz A, Jimenez B (2005) 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene 24:6533–6544

    CAS  PubMed  Google Scholar 

  • Ferrer-Mayorga G, Gomez-Lopez G, Barbachano A, Fernandez-Barral A, Pena C, Pisano DG, Cantero R, Rojo F, Munoz A, Larriba MJ (2016) Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer. Gut. doi:10.1136/gutjnl-2015-310977

    PubMed  Google Scholar 

  • Garcia-Quiroz J, Rivas-Suarez M, Garcia-Becerra R, Barrera D, Martinez-Reza I, Ordaz-Rosado D, Santos-Martinez N, Villanueva O, Santos-Cuevas CL, Avila E, Gamboa-Dominguez A, Halhali A, Larrea F, Diaz L (2014) Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis. J Steroid Biochem Mol Biol 144 Pt A:215–222

  • Giangreco AA, Nonn L (2013) The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites. J Steroid Biochem Mol Biol 136:86–93

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Giangreco AA, Vaishnav A, Wagner D, Finelli A, Fleshner N, Van der Kwast T, Vieth R, Nonn L (2013) Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue. Cancer Prev Res (Phila) 6:483–494

    Article  CAS  Google Scholar 

  • Gocek E, Studzinski GP (2009) Vitamin D and differentiation in cancer. Crit Rev Clin Lab Sci 46:190–209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gocek E, Wang X, Liu X, Liu CG, Studzinski GP (2011) MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. Cancer Res 71:6230–6239

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez-Duarte RJ, Cazares-Ordonez V, Romero-Cordoba S, Diaz L, Ortiz V, Freyre-Gonzalez JA, Hidalgo-Miranda A, Larrea F, Avila E (2015) Calcitriol increases dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells. Biochem Cell Biol 93:376–384

    Article  CAS  PubMed  Google Scholar 

  • Guan H, Liu C, Chen Z, Wang L, Li C, Zhao J, Yu Y, Zhang P, Chen W, Jiang A (2013) 1,25-Dihydroxyvitamin D3 up-regulates expression of hsa-let-7a-2 through the interaction of VDR/VDRE in human lung cancer A549 cells. Gene 522:142–146

  • Guerit D, Philipot D, Chuchana P, Toupet K, Brondello JM, Mathieu M, Jorgensen C, Noel D (2013) Sox9-regulated miRNA-574-3p inhibits chondrogenic differentiation of mesenchymal stem cells. PLoS One 8:e62582

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hansen CM, Binderup L, Hamberg KJ, Carlberg C (2001) Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci 6:D820–D848

    CAS  PubMed  Google Scholar 

  • Haussler MR, Jurutka PW, Mizwicki M, Norman AW (2011) Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 25:543–559

    Article  CAS  PubMed  Google Scholar 

  • Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4:143–159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iosue I, Quaranta R, Masciarelli S, Fontemaggi G, Batassa EM, Bertolami C, Ottone T, Divona M, Salvatori B, Padula F, Fatica A, Lo-Coco F, Nervi C, Fazi F (2013) Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis 4:e926

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ji J, Zhang J, Huang G, Qian J, Wang X, Mei S (2009) Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 583:759–766

    Article  CAS  PubMed  Google Scholar 

  • Jiang F, Bao J, Li P, Nicosia SV, Bai W (2004) Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase. J Biol Chem 279:53213–53221

    Article  CAS  PubMed  Google Scholar 

  • Jorde R, Svartberg J, Joakimsen RM, Coucheron DH (2012) Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months. BMC Res Notes 5:245

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kasiappan R, Shen Z, Tse AK, Jinwal U, Tang J, Lungchukiet P, Sun Y, Kruk P, Nicosia SV, Zhang X, Bai W (2012) 1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498. J Biol Chem 287:41297–41309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kasiappan R, Sun Y, Lungchukiet P, Quarni W, Zhang X, Bai W (2014) Vitamin D suppresses leptin stimulation of cancer growth through microRNA. Cancer Res 74:6194–6204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10:126–139

    Article  CAS  PubMed  Google Scholar 

  • Komagata S, Nakajima M, Takagi S, Mohri T, Taniya T, Yokoi T (2009) Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b. Mol Pharmacol 76:702–709

    Article  CAS  PubMed  Google Scholar 

  • Kyo S, Inoue M (2002) Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene 21:688–697

    Article  CAS  PubMed  Google Scholar 

  • Lamprecht SA, Lipkin M (2003) Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 3:601–614

    Article  CAS  PubMed  Google Scholar 

  • Larriba MJ, Ordonez-Moran P, Chicote I, Martin-Fernandez G, Puig I, Munoz A, Palmer HG (2011) Vitamin D receptor deficiency enhances Wnt/beta-catenin signaling and tumor burden in colon cancer. PLoS One 6:e23524

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Larriba MJ, Gonzalez-Sancho JM, Barbachano A, Niell N, Ferrer-Mayorga G, Munoz A (2013) Vitamin D is a multilevel repressor of Wnt/b-catenin signaling in cancer cells. Cancers (Basel) 5:1242–1260

    Article  Google Scholar 

  • Lee HJ, Muindi JR, Tan W, Hu Q, Wang D, Liu S, Wilding GE, Ford LA, Sait SN, Block AW, Adjei AA, Barcos M, Griffiths EA, Thompson JE, Wang ES, Johnson CS, Trump DL, Wetzler M (2014) Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. Cancer 120:521–529

    Article  CAS  PubMed  Google Scholar 

  • Li F, Zhang A, Shi Y, Ma Y, Du Y (2015) 1alpha,25-Dihydroxyvitamin D3 prevents the differentiation of human lung fibroblasts via microRNA-27b targeting the vitamin D receptor. Int J Mol Med 36:967–974

    CAS  PubMed  PubMed Central  Google Scholar 

  • Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142–153

    Article  CAS  PubMed  Google Scholar 

  • Liu PT, Wheelwright M, Teles R, Komisopoulou E, Edfeldt K, Ferguson B, Mehta MD, Vazirnia A, Rea TH, Sarno EN, Graeber TG, Modlin RL (2012) MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med 18:267–273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lopes N, Carvalho J, Duraes C, Sousa B, Gomes M, Costa JL, Oliveira C, Paredes J, Schmitt F (2012) 1alpha,25-Dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation. Anticancer Res 32:249–257

    CAS  PubMed  Google Scholar 

  • Lutherborrow M, Bryant A, Jayaswal V, Agapiou D, Palma C, Yang YH, Ma DD (2011) Expression profiling of cytogenetically normal acute myeloid leukemia identifies microRNAs that target genes involved in monocytic differentiation. Am J Hematol 86:2–11

    Article  CAS  PubMed  Google Scholar 

  • Ma Y, Hu Q, Luo W, Pratt RN, Glenn ST, Liu S, Trump DL, Johnson CS (2015) 1alpha,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells. J Steroid Biochem Mol Biol 148:166–171

    Article  CAS  PubMed  Google Scholar 

  • Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE (2000) 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 87:214–220

    Article  CAS  PubMed  Google Scholar 

  • Min D, Lv XB, Wang X, Zhang B, Meng W, Yu F, Hu H (2013) Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity. Br J Cancer 109:723–730

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mohri T, Nakajima M, Takagi S, Komagata S, Yokoi T (2009) MicroRNA regulates human vitamin D receptor. Int J Cancer 125:1328–1333

    Article  CAS  PubMed  Google Scholar 

  • Padi SK, Zhang Q, Rustum YM, Morrison C, Guo B (2013) MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. Gastroenterology 145:437–446

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, Munoz A (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154:369–387

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pan YZ, Gao W, Yu AM (2009) MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 37:2112–2117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peng X, Vaishnav A, Murillo G, Alimirah F, Torres KE, Mehta RG (2010) Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells. J Cell Biochem 110:1324–1333

    Article  CAS  PubMed  Google Scholar 

  • Peng W, Wang K, Zheng R, Derwahl M (2016) 1,25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest. Endocr Res 41:71–80

    Article  CAS  PubMed  Google Scholar 

  • Salvatori B, Iosue I, Djodji Damas N, Mangiavacchi A, Chiaretti S, Messina M, Padula F, Guarini A, Bozzoni I, Fazi F, Fatica A (2011) Critical role of c-Myc in acute myeloid leukemia involving direct regulation of miR-26a and histone methyltransferase EZH2. Genes Cancer 2:585–592

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Salvatori B, Iosue I, Mangiavacchi A, Loddo G, Padula F, Chiaretti S, Peragine N, Bozzoni I, Fazi F, Fatica A (2012) The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis 3:e413

  • Shah MS, Davidson LA, Chapkin RS (2012) Mechanistic insights into the role of microRNAs in cancer: influence of nutrient crosstalk. Front Genet 3:305

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shany S, Sigal-Batikoff I, Lamprecht S (2016) Vitamin D and myofibroblasts in fibrosis and cancer: at cross-purposes with TGF-beta/SMAD signaling. Anticancer Res 36:6225–6234

    Article  PubMed  Google Scholar 

  • Supic G, Jagodic M, Magic Z (2013) Epigenetics: a new link between nutrition and cancer. Nutr Cancer 65:781–792

    Article  CAS  PubMed  Google Scholar 

  • Supic G, Wagner D, Magic Z (2016) Epigenetic impact of bioactive dietary compounds in cancer chemoprevention. In: Ullah FM, Ahmad A (eds) Critical dietary factors in cancer chemoprevention. Springer International Publishing, Cham, pp 153–181

    Chapter  Google Scholar 

  • Thorne JL, Maguire O, Doig CL, Battaglia S, Fehr L, Sucheston LE, Heinaniemi M, O’Neill LP, McCabe CJ, Turner BM, Carlberg C, Campbell MJ (2011) Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells. Nucleic Acids Res 39:2045–2056

    Article  CAS  PubMed  Google Scholar 

  • Ting HJ, Messing J, Yasmin-Karim S, Lee YF (2013) Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D. J Biol Chem 288:1–9

    Article  CAS  PubMed  Google Scholar 

  • Vuolo L, Di Somma C, Faggiano A, Colao A (2012) Vitamin D and cancer. Front Endocrinol (Lausanne) 3:58

    CAS  Google Scholar 

  • Wang QM, Studzinski GP, Chen F, Coffman FD, Harrison LE (2000) p53/56(lyn) antisense shifts the 1,25-dihydroxyvitamin D3-induced G1/S block in HL60 cells to S phase. J Cell Physiol 183:238–246

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Gocek E, Liu CG, Studzinski GP (2009) MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3. Cell Cycle 8:736–741

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang WL, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP (2011) Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer 10:58

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang WL, Welsh J, Tenniswood M (2013) 1,25-Dihydroxyvitamin D3 modulates lipid metabolism in prostate cancer cells through miRNA mediated regulation of PPARA. J Steroid Biochem Mol Biol 136:247–251

    Article  CAS  PubMed  Google Scholar 

  • Zhang L, Stokes N, Polak L, Fuchs E (2011) Specific microRNAs are preferentially expressed by skin stem cells to balance self-renewal and early lineage commitment. Cell Stem Cell 8:294–308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zimmerman EI, Dollins CM, Crawford M, Grant S, Nana-Sinkam SP, Richards KL, Hammond SM, Graves LM (2010) Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia. Mol Pharmacol 78:811–817

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank professor Weng-Onn Lui from the Karolinska Institute for valuable suggestions and comments on the review and professor Steve Quarrie for help in English editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katarina Zeljic.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Communicated by S. Hohmann.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 130 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zeljic, K., Supic, G. & Magic, Z. New insights into vitamin D anticancer properties: focus on miRNA modulation. Mol Genet Genomics 292, 511–524 (2017). https://doi.org/10.1007/s00438-017-1301-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00438-017-1301-9

Keywords

Navigation